The purpose of this study is to better understand brain function and psychiatric and neurological illness when taking Invega or Risperdal. The objective is to compare the brain effects of Invega to Risperdal in patients with Schizophrenia. This comparison will be evaluated with PET imaging, fMRI, and neurological ratings and assessments.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
96
2mg - 8mg per day, for the duration of participation in the study
6mg - 12mg per day, for the duration of participation in the study
UC Irvine
Irvine, California, United States
RECRUITINGComparison of BOLD signal activation and FDG metabolism of the DLPFC, superior temporal gyrus and amygdala, and their interaction between Invega and Risperdal
Time frame: approximately 6-10 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.